Cite
Zhou L, Huntington K, Zhang S, et al. Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells. bioRxiv. 2020;doi: 10.1101/2020.08.02.230839.
Zhou, L., Huntington, K., Zhang, S., Carlsen, L., So, E. Y., Parker, C., Sahin, I., Safran, H., Kamle, S., Lee, C. M., Lee, C. G., Elias, J. A., Campbell, K. S., Naik, M. T., Atwood, W. J., Youssef, E., Pachter, J. A., Navaraj, A., Seyhan, A. A., Liang, O., & El-Deiry, W. S. (2020). Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.08.02.230839
Zhou, Lanlan, et al. "Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells." bioRxiv : the preprint server for biology vol. (2020). doi: https://doi.org/10.1101/2020.08.02.230839
Zhou L, Huntington K, Zhang S, Carlsen L, So EY, Parker C, Sahin I, Safran H, Kamle S, Lee CM, Lee CG, Elias JA, Campbell KS, Naik MT, Atwood WJ, Youssef E, Pachter JA, Navaraj A, Seyhan AA, Liang O, El-Deiry WS. Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells. bioRxiv. 2020 Sep 02; doi: 10.1101/2020.08.02.230839. PMID: 32793908; PMCID: PMC7418728.
Copy
Download .nbib